Trial Site Detail

 

Drug:
NN3201
Trial:
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

Case Comprehensive Cancer Center

     
Cleveland , OH 44106
USA

 

Principal Investigator:
Ankit Mangla, MD
Contact:
(216) 844-3951 ankit.mangla@uhhospitals.org
Activation Status of this Site:
Active
Notes about this Site:
Case Comprehensive Cancer Center Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.